Website stats for Biolinerx - biolinerx.com
Partnering In-licensing BioLineRx is committed to the identification, in-licensing and systematic development of promising therapeutic candidates. Through this strategy, BioLineRx is building a pipeline of powerful technologies in oncology. Out-licensing BioLineRx seeks to collaborate with leading global pharmaceutical companies with a proven track record in clinical experience, for comple...
biolinerx.com was registered 2 decades 11 months ago. It has a alexa rank of #747,967 in the world. It is a domain having .com extension. It is estimated worth of $ 1,680.00 and have a daily income of around $ 7.00. As no active threats were reported recently, biolinerx.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 1,172 |
| Daily Pageviews: | 2,344 |
Estimated Valuation
| Income Per Day: | $ 7.00 |
| Estimated Worth: | $ 1,680.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 747,967 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
89.200.137.201
Hosted Country:
GB
Location Latitude:
51.4562Location Longitude:
-0.97113Traffic Classification
| Total Traffic: | Not Applicable |
| Direct Traffic: | Not Applicable |
| Referral Traffic: | Not Applicable |
| Search Traffic: | Not Applicable |
| Social Traffic: | Not Applicable |
| Mail Traffic: | Not Applicable |
| Display Traffic: | Not Applicable |
Search Engine Results For biolinerx.com
BioLineRx - Home | Facebook
BioLineRx, Modi`in. 474 likes · 4 were here. BioLineRx is a publicly-traded ( NASDAQ/TASE: BLRX), clinical-stage biopharmaceutical company.
BioLineRx Email Format | biolinerx.com Emails - RocketReach
BioLineRx uses 6 email formats: 1. [email protected] (31.1%). Enter a name to find & verify an email >>>
BiolineRx | Start-Up Nation Finder
BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. Its pipeline currently consists of BL-8040, a platform for multiple cancer and ...
BioLineRx - Overview, News & Competitors | ZoomInfo.com
View BioLineRx (www.biolinerx.com) location in Jerusalem, Israel , revenue, industry and description. Find related and similar companies as well as employees ...
BioLineRx Reports First Quarter 2021 Financial Results and ...
26 May 2021 ... BioLineRx Ltd. (NASDAQ/TASE: BLRX) is a late clinical-stage biopharmaceutical company focused on oncology. The Company's business model ...
BioLine RX Ltd - Company Profile and News - Bloomberg Markets
BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs. CURRENT PRICE.
BioLineRx Ltd. - Consensus Indicates Potential 252.3% Upside ...
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. ... BioLineRx Ltd. was founded in 2003 and is headquartered in ...
BiolineRx - Crunchbase Company Profile & Funding
BioLineRx is a clinical-stage, publicly-traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel.
BiolineRx - Email Address Format & Contact Phone Number - Lusha
BioLineRx is a clinicalstage publiclytraded NASDAQ TASE BLRX biopharmaceutical development company based in Jerusalem Israel. icon ...
BioLineRx Ltd. SEC Registration - SEC Report
BioLineRx Ltd is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all ...
BioLineRx: Home
BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 6 |
| H3 Headings: | 2 | H4 Headings: | 12 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | Not Applicable |
| Google Adsense: | Not Applicable | Google Analytics: | UA-141223009-1 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Motixafortide BL8040 | 8 | 2.286 % | No |
| Pipeline Motixafortide | 5 | 1.429 % | No |
| BL8040 Solid | 3 | 0.857 % | No |
| BioLineRx is | 2 | 0.571 % | No |
| in oncology | 2 | 0.571 % | No |
| minutes See | 2 | 0.571 % | No |
| See terms | 2 | 0.571 % | No |
| committed to | 2 | 0.571 % | No |
| Request IR | 2 | 0.571 % | No |
| Information Request | 2 | 0.571 % | No |
| IR Contacts | 2 | 0.571 % | No |
| Contacts Careers | 2 | 0.571 % | No |
| Careers Contact | 2 | 0.571 % | No |
| 30 minutes | 2 | 0.571 % | No |
| up to | 2 | 0.571 % | No |
| to the | 2 | 0.571 % | No |
| peripheral blood | 2 | 0.571 % | No |
| of the | 2 | 0.571 % | No |
| BL8040 mobilizes | 2 | 0.571 % | No |
| cells to | 2 | 0.571 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Coverage SEC Filings Corporate | 2 | 0.571 % | No |
| SEC Filings Corporate Governance | 2 | 0.571 % | No |
| up to 30 minutes | 2 | 0.571 % | No |
| Analyst Coverage SEC Filings | 2 | 0.571 % | No |
| Financials Analyst Coverage SEC | 2 | 0.571 % | No |
| News Events Financials Analyst | 2 | 0.571 % | No |
| Events Financials Analyst Coverage | 2 | 0.571 % | No |
| Corporate Governance Information Request | 2 | 0.571 % | No |
| Governance Information Request IR | 2 | 0.571 % | No |
| 30 minutes See terms | 2 | 0.571 % | No |
| to 30 minutes See | 2 | 0.571 % | No |
| Delayed up to 30 | 2 | 0.571 % | No |
| IR Contacts Careers Contact | 2 | 0.571 % | No |
| Information Request IR Contacts | 2 | 0.571 % | No |
| Request IR Contacts Careers | 2 | 0.571 % | No |
| Performance News Events Financials | 2 | 0.571 % | No |
| Filings Corporate Governance Information | 2 | 0.571 % | No |
| Our Team Board of | 2 | 0.571 % | No |
| Pipeline Motixafortide BL8040 AGI134 | 2 | 0.571 % | No |
| Board of Directors Pipeline | 2 | 0.571 % | No |
Mobile Friendly Check
Mobile Friendly : Unknown
Score : Unknown
No data to show.
Websites Hosted on Same IP (i.e. 89.200.137.201)
Creative Marketing & PR Communications Agency | London | Cambridge...
Clarify the complex. Make the memorable. Specialists in strategy, branding, digital, Public Relations & advertising work side-by-side to deliver cross-channel creativity.
5,272,346 
$ 240.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Thu, 22 Apr 2021 00:02:34 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate
Pragma: no-cache
Content-Encoding: gzip
Vary: Accept-Encoding
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8
Domain Information
| Domain Registrar: |
Domain The Net Technologies Ltd.
|
|---|---|
| Registration Date: | 2003-05-25 2 decades 11 months 3 weeks ago |
| Last Modified: | 2021-04-04 3 years 1 month 2 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| custdns.barakitc.co.il | |
194.90.1.5 |  Israel |
| ns.barak.net.il | |
212.150.48.169 | Israel |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| biolinerx.com | A | 295 |
IP: 89.200.137.201 |
| biolinerx.com | NS | 300 |
Target: ns1.barak.net.il |
| biolinerx.com | NS | 300 |
Target: ns.barak.net.il |
| biolinerx.com | SOA | 300 |
MNAME: ns.barak.net.il RNAME: hostmaster.barak.net.il Serial: 2019061101 Refresh: 28800 Retry: 7200 Expire: 604800 |
| biolinerx.com | MX | 300 |
Target: biolinerx-com.mail.protection.outlook.com |
| biolinerx.com | TXT | 300 |
TXT: MS=ms98375525 |
| biolinerx.com | TXT | 300 |
TXT: v=spf1 ip4:62.90.205.130 include:spf.protection.outlook.com -all |
| biolinerx.com | TXT | 300 |
TXT: zH58DJq6A34eJoE2kYtUm7hc42MRCE3lEAJr6mht z8F/bPnsHnVOs8P1sgNWVx/J5XgDfxyOqTvop7O8 enCllQ== |
Alexa Traffic Rank
Alexa Search Engine Traffic
Full WHOIS Lookup
Registry Domain ID:
98325382_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.domainthenet.com
Registrar URL:
http://www.DomainTheNet.com
Updated Date:
2021-04-04T11:39:06Z
Creation Date:
2003-05-25T09:07:31Z
Registry Expiry Date:
2023-05-25T09:07:31Z
Registrar: Domain The Net Technologies
Ltd.
Registrar IANA ID: 10007
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
972-3-7600500
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
CUSTDNS.BARAKITC.CO.IL
Name Server: NS.BARAK.NET.IL
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2021-04-22T00:02:23Z
Similarly Ranked Websites
Backcheck Canada - Sterling Backcheck
Need to run a backcheck in Canada? Sterling Backcheck offers personal criminal record checks and Backcheck badge verification.
747,970 $ 1,680.00
Bleu de chauffe - Sacs en cuir Fabriqués en France
Inspirés par l'esprit workwear, les sacs Bleu de Chauffe en cuir tanné végétal réinventent l'univers des sacs de métier : simples, pratiques et stylés pour un usage au quotidien
747,980 $ 1,680.00